Indian CEO To Pay $50 Million As Settlement
Nostrum Laboratories, a pharmaceutical company in the US, along with its Indian-origin CEO Nirmal Mulye, has agreed to resolve allegations of knowingly underpaying Medicaid rebates for their drug Nitrofurantoin Oral Suspension (Nitro OS).
As part of the settlement, they have committed...
1 November, 2023
